The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...
Conference call to discuss positive initial Phase 1 clinical data today at 8:30 a.m. ETCAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE ...
NICE's endorsement of olaparib, produced by AstraZeneca, marks a crucial step forward in the treatment of breast cancer. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback